Biggest News Aggregation in the World
📰 Standard Definitions News

Standard Definitions News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Standard Definitions. Real-time updates on events, politics, business and more.

Adjuvant Abemaciclib Provides Survival Benefit in Chinese Breast Cancer Population

Abemaciclib plus endocrine therapy delivered sustained survival benefits with a tolerable safety profile when used as adjuvant treatment in Chinese patients with high-risk, hormone receptor–positive, HER2-negative early breast cancer.
Abemaciclib Verzenio Zhimin Shao Eli Lilly Fudan University Shanghai Cancer Center Breast Cancer Annual Congress Cancer Annual

ISDA Launches Standard Definitions For The Voluntary Carbon Market

<p><span>ISDA has published new industry documentation for the trading of verified carbon credits (VCCs), as part of a broad effort to support the transition to a green economy by developing robust legal and risk management standards for markets related to environmental, social and governance (ESG) activities.</span></p>
Hong Kong United Kingdom Scott Omalia Integrity Council For The Voluntary Carbon Market Carbon Credit Transactions Definitions Scotto Malia

ICC lays out roadmap for the future of trade finance | Global Trade Review (GTR)

The International Chamber of Commerce (ICC) has published a framework for the trade finance industry as it grapples with the challenge of better serving smaller businesses. The document, titled Reconceiving the Trade Finance Ecosystem, sets out a road map for digitally connecting and facilitating interoperation among existing trade finance networks through sets of shared standards, ...
John Denton Bob Sternfels Digital Container Shipping Association Digital Standards Initiative International Chamber Global Supply Chain Finance Forum

Lilly Presents Patient-Reported Outcomes from the Positive Phase 3 monarchE Trial for Verzenio® at St. Gallen Virtual Congress 2021

Share this article Share this article INDIANAPOLIS, March 17, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced patient-reported outcomes (PRO) for the investigational use of Verzenio ® (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) high risk early breast cancer (EBC). The PRO analysis included patients in both arms of the study and m...
United States Saram Tolaney Courtney Kasinger Kevin Hern Prnewswire Eli Lilly Eli Lilly

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science